☰

Eric S. Soehnlen, Ph.D. - Publications

Affiliations: 
2012 Chemistry Kent State University, Kent, OH, United States 
Area:
Analytical Chemistry, Nanoscience
Tree Info Similar researchers PubMed Report error

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Beals N, Thiagarajan PS, Soehnlen E, Das A, Reizes O, Lathia JD, Basu S. Five-Part Pentameric Nanocomplex Shows Improved Efficacy of Doxorubicin in CD44+ Cancer Cells. Acs Omega. 2: 7702-7713. PMID 30023561 DOI: 10.1021/acsomega.7b01168  0.434
2013 Shoffstall AJ, Everhart LM, Varley ME, Soehnlen ES, Shick AM, Ustin JS, Lavik EB. Tuning ligand density on intravenous hemostatic nanoparticles dramatically increases survival following blunt trauma. Biomacromolecules. 14: 2790-7. PMID 23841817 DOI: 10.1021/Bm400619V  0.431
2011 Das A, Soehnlen E, Woods S, Hegde R, Henry A, Gericke A, Basu S. VEGFR-2 targeted cellular delivery of doxorubicin by gold nanoparticles for potential antiangiogenic therapy Journal of Nanoparticle Research. 13: 6283-6290. DOI: 10.1007/S11051-011-0300-8  0.518
2010 Shokouhimehr M, Soehnlen ES, Hao J, Griswold M, Flask C, Fan X, Basilion JP, Basu S, Huang SD. Dual purpose Prussian blue nanoparticles for cellular imaging and drug delivery: A new generation of T1-weighted MRI contrast and small molecule delivery agents Journal of Materials Chemistry. 20: 5251-5259. DOI: 10.1039/B923184F  0.545
2010 Shokouhimehr M, Soehnlen ES, Khitrin A, Basu S, Huang SD. Biocompatible Prussian blue nanoparticles: Preparation, stability, cytotoxicity, and potential use as an MRI contrast agent Inorganic Chemistry Communications. 13: 58-61. DOI: 10.1016/J.Inoche.2009.10.015  0.532
Show low-probability matches.